Pennant Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Pennant Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-78,000	Closed	-$2.18M	–	20
2018 Q2	$2.18M	Sell	78,000 -1,396,524	-95%	-$37.4M	1.03%	19
2018 Q1	$36.7M	Sell	1,474,524 -281,830	-16%	-$6.86M	16.81%	1
2017 Q4	$42.6M	Buy	1,756,354 +134,288	+8%	+$3.54M	3.86%	7
2017 Q3	$44.8M	Sell	1,622,066 -233,000	-13%	-$6.21M	2.75%	17
2017 Q2	$46.5M	Sell	1,855,066 -72,342	-4%	-$1.79M	2.73%	17
2017 Q1	$51.7M	Hold	1,927,408	–	–	2.45%	21
2016 Q4	$50.5M	Buy	1,927,408 +1,530,043	+385%	+$37.8M	1.97%	20
2016 Q3	$9.93M	Buy	+397,365	New	+$9.26M	0.35%	37

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Pennant Capital Management's NXTM Position: Q3 2018 in Review

Pennant Capital Management sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 78,000 shares — an estimated $2.18M sold.

Pennant Capital Management first reported a position in NXTM in Q3 2016 and held it in 8 quarters. The position peaked at $51.7M in Q1 2017. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

Pennant Capital Management reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
Pennant Capital Management sold 78,000 NxStage Medical Inc. shares in Q3 2018, an estimated $2.18M.
Pennant Capital Management first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 8 quarters.
Pennant Capital Management's NxStage Medical Inc. position peaked at $51.7M in Q1 2017.
175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Pennant Capital Management's 13F filing for Q3 2018.